NCT04089579View on ClinicalTrials.gov

hCT-MSC in Children With Autism Spectrum Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

October 12, 2020

Primary Completion Date

May 2, 2023

Study Completion Date

February 1, 2024

Conditions
AutismAutism Spectrum Disorder
Interventions
BIOLOGICAL

Cord Tissue Mesenchymal Stromal Cells

Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC), isolated and expanded from umbilical cord tissue from allogeneic unrelated donors. One dose of 6x10e6 cells/kg administered intravenously.

OTHER

Placebo Infusion

Placebo comparative infusion

Trial Locations (1)

27705

Duke University Medical Center, Durham

Sponsors

Collaborators (1)

Cryo-Cell International
All Listed Sponsors
collaborator

The Marcus Foundation

OTHER

collaborator

Cryo-Cell International

UNKNOWN

lead

Joanne Kurtzberg, MD

OTHER